| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- article scientific (oc)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artikulong pang-agham (tl)
- artykuł naukowy (pl)
- artículu científicu (ast)
- bilimsel makale (tr)
- scienca artikolo (eo)
- teaduslik artikkel (et)
- tieteellinen artikkeli (fi)
- tudományos cikk (hu)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- επιστημονικό άρθρο (el)
- научна статия (bg)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- სამეცნიერო სტატია (ka)
- บทความทางวิทยาศาสตร์ (th)
- artikel ilmiah (id)
- bài báo khoa học (vi)
- naučni članak (sr-el)
- мақолаи илмӣ (tg-cyrl)
- научни чланак (sr-ec)
- article scientifique (fr)
- 1980 nî lūn-bûn (nan)
- 1980年の論文 (ja)
- 1980년 논문 (ko)
- artículo científico publicado en 1980 (es)
- 1980年学术文章 (zh-cn)
- 1980年学术文章 (zh-sg)
- 1980年学术文章 (zh-hans)
- 1980年学术文章 (wuu)
- 1980年学术文章 (zh-my)
- 1980年學術文章 (zh-hk)
- 1980年學術文章 (zh-tw)
- 1980年學術文章 (zh-hant)
- 1980年學術文章 (yue)
- 1980年學術文章 (zh-mo)
- наукова стаття, опублікована в липні 1980 (uk)
- scientific article published in July 1980 (en-ca)
- scientific article published in July 1980 (en-gb)
- scientific article published in July 1980 (en)
- مقالة علمية نشرت في يوليو 1980 (ar)
- জুলাই ১৯৮০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn)
- 1980年学术文章 (zh)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - Duggan DE
- Hwang SS
- Hooke KF
|
| rdfs:label
| - Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (en)
- Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (nl)
|
| skos:prefLabel
| - Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (en)
- Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (nl)
|
| name
| - Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (en)
- Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (nl)
|
| title
| |
| title
| - Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| is about
of | |
| is cites work
of | - Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
- Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
- NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling
- Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
- COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs
- Prodrugs. Do they have advantages in clinical practice?
- The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits
- Clinical pharmacokinetics of sulindac. A dynamic old drug
- Growth compensatory role of sulindac sulfide-induced thrombospondin-1 linked with ERK1/2 and RhoA GTPase signaling pathways
- Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator
- Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)